MGMT and glioblastoma: By simultaneously reducing the mRNA expression of stemness-associated markers and the MGMT gene in these established GBM cell lines, ATRA demonstrates the potential at the transcriptional level for impacting both stem-like properties and TMZ resistance mechanisms.